Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Cancer Prev Res (Phila). 2014 Nov 3;8(1):27–36. doi: 10.1158/1940-6207.CAPR-14-0193

Figure 1. Effects of β-AR ligands on EGF-mediated neoplastic transformation of JB6 P+ cells.

Figure 1

Effects of EGF or carvedilol (Car) on JB6 P+ cell transformation (A). The β-AR agonist isoproterenol (Iso) (B), the β-blockers carvedilol (C) and atenolol (Aten) (D) showed different degree of inhibition of EGF-induced cell transformation. Groups with different Greek letters are statistically different (p < 0.05) as determined by ANOVA with Tukey-Kramer post hoc test.